Complement in kidney disease: core curriculum 2015.
作者信息
Thurman Joshua M
机构信息
Division of Nephrology and Hypertension, University of Colorado Denver School of Medicine, Aurora, CO.
出版信息
Am J Kidney Dis. 2015 Jan;65(1):156-68. doi: 10.1053/j.ajkd.2014.06.035. Epub 2014 Oct 18.
Abstract
摘要
相似文献
1
Complement in kidney disease: core curriculum 2015.
Am J Kidney Dis. 2015 Jan;65(1):156-68. doi: 10.1053/j.ajkd.2014.06.035. Epub 2014 Oct 18.
2
Complement-mediated kidney diseases.
Mol Immunol. 2020 Dec;128:175-187. doi: 10.1016/j.molimm.2020.10.015. Epub 2020 Nov 1.
3
Complement and the Kidney: An Overview.
Adv Chronic Kidney Dis. 2020 Mar;27(2):86-94. doi: 10.1053/j.ackd.2019.10.003.
4
Complement and kidney disease.
Curr Opin Nephrol Hypertens. 2013 May;22(3):295-301. doi: 10.1097/MNH.0b013e32835ff9cb.
5
Complement in glomerular diseases.
Nephrology (Carlton). 2018 Oct;23 Suppl 4:11-15. doi: 10.1111/nep.13461.
6
The role of the complement system in renal injury.
Semin Nephrol. 1992 Sep;12(5):408-27.
7
Targeting the complement cascade: novel treatments coming down the pike.
Kidney Int. 2016 Oct;90(4):746-52. doi: 10.1016/j.kint.2016.04.018. Epub 2016 Jun 18.
8
Complement inhibitors are not useful in secondary hemolytic uremic syndromes.
Kidney Int. 2019 Oct;96(4):829-833. doi: 10.1016/j.kint.2019.08.001.
9
Role of the Complement Pathway in Inflammatory Skin Diseases: A Focus on Hidradenitis Suppurativa.
J Invest Dermatol. 2020 Mar;140(3):531-536.e1. doi: 10.1016/j.jid.2019.09.009. Epub 2019 Dec 20.
10
O Complement, Where Aren't Thou.
Adv Chronic Kidney Dis. 2020 Mar;27(2):83-85. doi: 10.1053/j.ackd.2020.02.001.
引用本文的文献
1
The complement system and kidney cancer: pathogenesis to clinical applications.
J Clin Invest. 2025 May 1;135(9). doi: 10.1172/JCI188351.
2
Clinical characteristics and short term outcomes of childhood immune complex membranoproliferative glomerulonephritis and C3 glomerulopathy: a single centre retrospective study.
BMC Nephrol. 2025 Mar 22;26(1):143. doi: 10.1186/s12882-025-04078-3.
3
Evaluation of a proteomic signature coupled with the kidney failure risk equation in predicting end stage kidney disease in a chronic kidney disease cohort.
Clin Proteomics. 2024 May 18;21(1):34. doi: 10.1186/s12014-024-09486-5.
4
The role of innate immunity in diabetic nephropathy and their therapeutic consequences.
J Pharm Anal. 2024 Jan;14(1):39-51. doi: 10.1016/j.jpha.2023.09.003. Epub 2023 Sep 9.
5
The Role of the Complement System in the Pathogenesis of Infectious Forms of Hemolytic Uremic Syndrome.
Biomolecules. 2023 Dec 27;14(1):39. doi: 10.3390/biom14010039.
6
Clinical Safety and Efficacy of Pegcetacoplan in a Phase 2 Study of Patients with C3 Glomerulopathy and Other Complement-Mediated Glomerular Diseases.
Kidney Int Rep. 2023 Aug 25;8(11):2284-2293. doi: 10.1016/j.ekir.2023.08.033. eCollection 2023 Nov.
7
Role of perivascular cells in kidney homeostasis, inflammation, repair and fibrosis.
Nat Rev Nephrol. 2023 Nov;19(11):721-732. doi: 10.1038/s41581-023-00752-7. Epub 2023 Aug 22.
8
Biomarkers of aging.
Sci China Life Sci. 2023 May;66(5):893-1066. doi: 10.1007/s11427-023-2305-0. Epub 2023 Apr 11.
9
New insight of complement system in the process of vascular calcification.
J Cell Mol Med. 2023 May;27(9):1168-1178. doi: 10.1111/jcmm.17732. Epub 2023 Apr 1.
10
Overlap of C3 Glomerulopathy and Thrombotic Microangiopathy: A Case Series.
Kidney Int Rep. 2022 Dec 24;8(3):619-627. doi: 10.1016/j.ekir.2022.12.009. eCollection 2023 Mar.
Zotero 插件